Novo US Market Leadership Strengthened with New US Chief
The leadership change at Novo Nordisk reflects its commitment to securing Novo US market leadership amid increasing competition and pricing pressures in the
Pfizer Novo Nordisk Rivalry Escalates as Novo Nordisk Calls
The Pfizer Novo Nordisk rivalry highlights the intense competition among leading pharmaceutical companies for assets in the growing obesity drug sector,
Older drug price trends: Why prices stay high revealed in
Understanding older drug price trends reveals that costs for some medications remain high due to market dynamics, patent protections, and strategic pricing